Clinical and economic analyses of antimicrobial therapy in rever wards of a Hong Kong teaching hospital

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 12, 2007, Pages 654-658

  Mak, C F ^a   Choi, D K M ^a   Wong, R S M ^b   You, Joyce H S ^a,c  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Faculty of Medicine   (Hong Kong)

Author keywords

Antimicrobials; Clinical outcome; Cost analysis; Hong Kong; Rever wards

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONFIDENCE INTERVAL; DEMOGRAPHY; DOSE CALCULATION; DRUG TREATMENT FAILURE; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK FACTOR; TEACHING HOSPITAL;

EID: 37249073419     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45654     Document Type: Article

References (20)

1. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med. 2002; 162: 682-688.
2. Berild D, Ringertz SH, Lelek M, Fosse B. Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital. Scand J Infect Dis. 2001; 33: 63-67.
3. Berild D, Mohseni A, Diep LM, Jensenius M, Ringertz SH. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs. J Antimicrob Chemother. 2006; 57: 326-330.
4. Cabre M, Bolivar I, Pera G, Pallares R. Factors influencing length of hospital stay in community-acquired pneumonia: a study in 27 community hospitals. Epidemiol Infect. 2004; 132:821-829.
5. Carriere KC, Jin Y, Marrie TJ. Outcomes and costs among seniors requiring hospitalization for community acquired pneumonia in Alberta. J Am Geriatr Soc. 2004; 52: 31-38.
6. Cheng CWR, Chan JCN, Tomlinson B, Woo KS, You JHS. Factors associated with healthcare utilization costs for statin therapy - a pilot study in Hong Kong. Int J Clin Pharmacol Ther. 2006; 44: 484-488.
7. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.
8. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999; 43: 459-465.
9. Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Intern Med. 2001; 16: 599-605.
10. HKSAR. Department of Health Annual Health Report 2003 - 2004. Accessed April 22, 2007, at http://www.info.gov.hk
11. Hunter KA, Dormaier GK. Pharmacist-managed intravenous to oral step-down program. Clin Ther. 1995; 17: 534-540.
12. Law WL, Hui HY, Young WM, You JHS. Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients - a cost analysis. Int J Clin Pharmacol Ther. 2007; 45: 264-270.
13. Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother. 2001; 35:1180-1185.
14. McLaughlin CM, Bodasing N, Boyter AC, Fenelon C, Fox JG, Seaton RA. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. QJM. 2005; 98: 745-752.
15. Menendez R, Ferrando D, Valles JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest. 2002; 122: 612-617.
16. Mol PG, Rutten WJ, Gans RO, Degener JE, Haaijer-Ruskamp FM. Adherence barriers to antimicrobial treatment guidelines in teaching hospital, The Netherlands. Emerg Infect Dis. 2004; 10: 522-525.
17. Spanish Pneumococcal Infection Study Network (G03/ 103). Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Infect Dis. 2005; 11: 919-924.
18. Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003; 23: 1615-1624.
19. You JHS, Lau WH, Lee IY, Yung MY, Ching JY, Chan FKC, Lee KKC. Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients - a cost-effectiveness analysis. Int J Clin Pharmacol Ther. 2006; 44: 149-153.
20. You JHS, Lo LPY, Chung IYK, Marasinghe T, Lee N, Ip M. Effect of an antimicrobial stewardship programme on the use of carbapenems in a Hong Kong teaching hospital - a pilot study. J Hosp Infect. 2007; 65: 378-379.